Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its boronic acid group enables Suzuki-Miyaura cross-coupling reactions, allowing efficient construction of biaryl structures in drug molecules. The presence of fluorine enhances binding affinity and metabolic stability in final active pharmaceutical ingredients. Commonly employed in medicinal chemistry for structure-activity relationship (SAR) studies due to its ability to modulate electronic and steric properties. Also utilized in the preparation of proteolysis targeting chimeras (PROTACs) and other targeted therapies.